Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

被引：0

作者：

Marx, Nikolaus ^{[1
]}

Mueller-Wieland, Dirk ^{[1
]}

Espinola-Klein, Christine ^{[2
]}

Halle, Martin ^{[3
]}

Birkenhagen, Annette ^{[4
]}

Diemert, Patrick ^{[5
]}

Mahfoud, Felix ^{[6
,9
]}

Wienbergen, Harm ^{[7
,8
]}

Schuett, Katharina ^{[1
]}

机构：

[1] Uniklin RTWH Aachen, Med Klin Kardiol Angiol & Internist Intensivmed 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] Univ Med Mainz, Zent Kardiol, Kardiol Angiol 3, Mainz, Germany

[3] Tech Univ Munich, TUM Sch Med & Hlth, Pravent Sportmed & Sportkardiol, TUM Univ klinikum rechts Isar, Munich, Germany

[4] Kardiol Angiol Praxis, Stollberg, Germany

[5] Univ Herz & Gefasszentrum Hamburg, Klinik & Poliklin Kardiol, Hamburg, Germany

[6] Univ klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

[7] Bremer Inst Herz & Kreislaufforsch, Stiftung Bremer Herzen, Gesundheit Nord Klinikverbund Bremen, Bremen, Germany

[8] Univ Lubeck, Med Klin 2, Lubeck, Germany

[9] Deutsch Gesell Kardiol Herz & Kreislaufforsch eV D, Kommiss Klin Kardiovask Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 03期

关键词：

Diabetes mellitus; Cardiovascular disease; Heart failure; Kidney failure; EJECTION FRACTION; KIDNEY OUTCOMES; HEART-FAILURE; TYPE-2; EMPAGLIFLOZIN; METAANALYSIS; FINERENONE; MORTALITY;

D O I：

10.1007/s12181-024-00689-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

引用

页码：256 / 265

页数：10

共 50 条

[21] Comments on the 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery
不详
REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (05): : 287 - 293
[22] Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings
Marx, Nikolaus
Schuett, Katharina
Mueller-Wieland, Dirk
Di Angelantonio, Emanuele
Herrington, William G.
Ajjan, Ramzi A.
Kautzky-Willer, Alexandra
Rocca, Bianca
Sattar, Naveed
Fauchier, Laurent
Lettino, Maddalena
Federici, Massimo
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2025,
[23] Comments on the 2023 guidelines of the ESC on infectious endocarditis
de Waha, Suzanne
Abdel-Wahab, Mohamed
Al-Nawas, Bilal
Buerke, Michael
Flachskampf, Frank A.
Huntgeburth, Michael
Mangner, Norman
Plicht, Bjoern
Tilz, Roland
Frantz, Stefan
Borger, Michael A.
KARDIOLOGIE, 2024, 18 (06): : 447 - 457
[24] Comments on the ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy. A Critical Vision of Spanish Cardiology
Alonso Gomez, Angel M.
Comin, Josep
Borras, Xavier
del Castillo, Silvia
Elvira Gonzalez, Ana
Mazon, Pilar
Monserrat, Lorenzo
Pijuan, Antonia
Salvador Sanz, Antonio
REVISTA ESPANOLA DE CARDIOLOGIA, 2012, 65 (02): : 113 - 118
[25] 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, Vera
Roos-Hesselink, Jolien W.
Bauersachs, Johann
Blomstrom-Lundqvist, Carina
Cifkova, Renata
De Bonis, Michele
Iung, Bernard
Johnson, Mark Richard
Kintscher, Ulrich
Kranke, Peter
Lang, Irene Marthe
Morals, Joao
Pieper, Petronella G.
Presbitero, Patrizia
Price, Susanna
Rosano, Giuseppe M. C.
Seeland, Ute
Simoncini, Tommaso
Swan, Lorna
Warnes, Carole A.
EUROPEAN HEART JOURNAL, 2018, 39 (34) : 3165 - +
[26] ESC Guidelines for the management of cardiovascular diseases during pregnancy (2018)
Regitz-Zagrosek, Vera
Roos-Hesselink, Jolien W.
Bauersachs, Johann
Blomstrom-Lundqvist, Carina
Cifkova, Renata
De Bonis, Michele
Iung, Bernard
Johnson, Mark Richard
Kintscher, Ulrich
Kranke, Peter
Lang, Irene Marthe
Morais, Joao
Pieper, Petronella G.
Presbitero, Patrizia
Price, Susanna
Rosano, Giuseppe M. C.
Seeland, Ute
Simoncini, Tommaso
Swan, Lorna
Warnes, Carole A.
KARDIOLOGIA POLSKA, 2019, 77 (03) : 245 - 326
[27] Comments on Guidelines on diabetes, pre-diabetes, and cardiovascular diseases
Alexandrov, An. A.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2007, 3 (04) : 100 - 103
[28] The first ESC Guidelines on the management of cardiovascular diseases during pregnancy
Taylor, Jennifer
EUROPEAN HEART JOURNAL, 2011, 32 (24) : 3055 - 3056
[29] Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
Zandecki, Lukasz
Janion-Sadowska, Agnieszka
Kurzawski, Jacek
Janion, Marianna
MEDICAL STUDIES-STUDIA MEDYCZNE, 2020, 36 (02) : 148 - 155
[30] Comments on the 2024 ESC guidelines for the management of peripheral arterial and aortic diseases
Avanzas, Pablo
Mazon, Pilar
Ribas, Rut Andrea
Amaro, Marisol Bravo
Fort, Alberto Cordero
Crespo, Marisa
Candil, F. Javier Jimenez
Momblan, Maria Antonia Martinez
Perez, Sonia Mirabet
Fores, Juan Sanchis
Carren, Marta Sitges
de la Torre, Jose M.
Llergo, Javier Torres
Vivas, David
Ruiz, Raquel Campuzano
Duque, Jose Antonio Alarcon
Doblas, Juan Jose Gomez
Rico, Rafael Mesa
Pineda, Soledad Ojeda
Sampio, Patricia Palau
Garcia, Enrique Maria San Norberto
SEC Working Group
SEC Guidelines Committe
REVISTA ESPANOLA DE CARDIOLOGIA, 2025, 78 (03): : 164 - 169

← 1 2 3 4 5 →